The IR team

We encourage all shareholders and investment professionals to contact us, should you have any questions or requests concerning Novozymes.
MRSN-2016

Martin Riise 
Head of Investor Relations

M: +45 3077 0738
mrsn@novozymes.com



KSDH-2016

Klaus Sindahl
Investor Relations, NA

M: +45 5363 0134
ksdh@novozymes.com



2016 in brief

Organic sales growth

2%



EBIT

27.9%

ROIC

25.1%

Annual report 2016

Take a look at our company’s performance in 2016, our strategy and trends shaping our business

Date Event Announcement
2017.01.18
Q4 financial statement EN DK
2016.10.26
Q3 financial statement EN DK
2016.08.10
Q2 financial statement EN DK
2016.04.20
Q1 financial statement EN DK

Key figures

Novozymes annual and quarterly key figures, five-year summary and long-term targets.

Corporate governance

Shareholder meetings, the board of directors and management team and the statutory report on corporate governance.

Meet us

An overview of investor events, roadshows, conference calls and shareholder meetings.